Marco Pugliese,Josette-Nicole Mahy Gehenne,Manuel Rodríguez Alluè,Juan Francisco Espinosa Parrilla,Noemí Virgili Treserres,Pilar Mancera Aroca,Andrea Pastén Zamorano
申请号：
US13520300
公开号：
US20130039905A1
申请日:
2011.01.04
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to the use of diazoxide or a pharmaceutically acceptable salt thereof at low doses to treat a CNS autoimmune demyelinating disease selected from selected from multiple sclerosis (MS), clinically isolated syndrome (CIS), tumefactive (tumor-like) M S, Marburgs acute M S, Balóss concentric sclerosis, acute disseminated encephalomyelitis (ADEM), post-vaccinal encephalitis (PVE), post-infectious encephalomyelitis (PIE) and neuromyelitis optica (NMO).
